On page 18 of the MD&A, it states: "Subsequent to April 30, 2017 we completed a private placement of 5,503,802 equity units, consisting of one common share and one common share purchase warrant, for gross proceeds of $CAD10 million, or $CAD1.80 per unit. We intend to complete an equity private placement within the next month; however, there is no assurance that the placement will be completed."

So in addition to the June 2017 equity offering, it sounds like they are working on another equity private placement to be completed by end of August. However, in the same section they also state that they are exploring non-dilutive alternatives. In any case.....we know they need additional funds, since "aggregate expenditures over the next twelve months under cancellable agreements with contract research organizations and central laboratories conducting the BETonMACE and other trials are estimated to total approximately $20 - 25 million."

Like Kelsee pointed out.....the news release this evening states: "An additional corporate financial update will take place prior to August 28th, 2017." We will find out soon enough about the loan extension/replacement as well as what dilutive or non-dilutive fund raising choice they have made.

GLTA,

BearDownAZ